We develop digital cardiac biomarkers
Who we are
We are a health technology company based in Finland and the United States. Originally an academic spinoff, we have over a decade of research and algorithm development as basis.
Our roots are in Turku, Finland, where researchers discovered that motion sensors found in modern smartphones could be harnessed for heart disease detection.
Today, our patented technology enables a digital cardiac biomarker for several major heart disease, representing a disruption in battling heart disease, the costliest and deadliest disease in the world.
CardioSignal is a brand and a product by Precordior.
In Short
✔ Based in Turku, Finland and Palo Alto, CA, USA.
✔ A team of 30+ people
✔ Available in over 15 countries
✔ Patented gyrocardiography technology
✔ 20+ peer-reviewed publications
✔ 10+ years of academic research
Meet some of our team members
-
Juuso Blomster
FOUNDER, CEO
-
Ilkka Korhonen
CHIEF TECHNOLOGY OFFICER
-
Kristiina Santalahti
RESEARCH & QUALITY DIRECTOR
-
Lasse Leppäkorpi
Operations Executive
Our mission: Transform cardiovascular care
The problem: Heart disease is the #1 killer in the world, accounting for over 20 million lives lost every year. Innovations in digital health have been suggested as a solution for the growing problem, but to advance earlier detection for hundreds of millions people living with significant heart disease risk factors, bottlenecks in the accessibility and scalability of technology need to be solved.
Our solution: The digital cardiac biomarkers we are developing for several major heart diseases can replace invasive and costly standard care technologies, enabling faster care and with lower cost.
We address the challenge of delayed diagnosis and growing disparity in heart disease care by developing new detection methods available to primary care, and building new remote care strategies that are accessible through smartphones - no additional devices needed.
Join our team
Interested in joining our team? Through a powerful combination of medical expertise, technological innovation, algorithm development, people-friendly design, and insights into wellbeing, we work to reduce the burden of heart disease.
Latest news
Contact
Customer support
support@cardiosignal.com
FINLAND
Address
Aurakatu 6
20100 Turku, Finland
Business ID: FI28009277
UNITED STATES
Address
470 Ramona St, Palo Alto, CA 94301, United States
Precordior Ltd. is supported by the European Union.
Project no. 954566 CardioSignal
Duration: 2020–2022
Topic: EIC-SMEInst-2018-2020
Type of action: SME-2b.
Further information:
Business area: Medical devices, mobile app solutions, cardiac monitoring
Class IIa medical device in Europe, ISO13485-certified medical device company, ISO27001-certification for information security